RGT Capital Management Ltd. acquired a new stake in Thermo Fisher Scientific Inc (NYSE:TMO) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,334 shares of the company’s stock, valued at approximately $212,000.
A number of other large investors have also bought and sold shares of the company. Parsec Financial Management Inc. increased its stake in Thermo Fisher Scientific by 0.6% in the third quarter. Parsec Financial Management Inc. now owns 1,938 shares of the company’s stock valued at $308,000 after buying an additional 12 shares in the last quarter. Choate Investment Advisors increased its stake in Thermo Fisher Scientific by 0.4% in the third quarter. Choate Investment Advisors now owns 3,358 shares of the company’s stock valued at $534,000 after buying an additional 15 shares in the last quarter. Quadrant Capital Group LLC increased its stake in Thermo Fisher Scientific by 0.6% in the third quarter. Quadrant Capital Group LLC now owns 2,844 shares of the company’s stock valued at $442,000 after buying an additional 18 shares in the last quarter. Savant Capital LLC increased its stake in Thermo Fisher Scientific by 1.2% in the third quarter. Savant Capital LLC now owns 1,718 shares of the company’s stock valued at $273,000 after buying an additional 20 shares in the last quarter. Finally, Dorsey & Whitney Trust CO LLC increased its stake in Thermo Fisher Scientific by 0.7% in the third quarter. Dorsey & Whitney Trust CO LLC now owns 3,079 shares of the company’s stock valued at $490,000 after buying an additional 21 shares in the last quarter. Institutional investors own 87.80% of the company’s stock.
Thermo Fisher Scientific Inc (NYSE:TMO) opened at 156.35 on Tuesday. The firm has a market cap of $61.70 billion, a price-to-earnings ratio of 30.71 and a beta of 1.10. Thermo Fisher Scientific Inc has a 12 month low of $123.96 and a 12 month high of $160.68. The firm’s 50-day moving average price is $146.97 and its 200-day moving average price is $149.58.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Tuesday, January 31st. The company reported $2.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.38 by $0.03. Thermo Fisher Scientific had a return on equity of 15.41% and a net margin of 11.06%. The company earned $4.95 billion during the quarter, compared to analysts’ expectations of $4.98 billion. During the same quarter in the previous year, the company posted $2.12 earnings per share. The business’s revenue was up 6.5% on a year-over-year basis. Equities research analysts predict that Thermo Fisher Scientific Inc will post $9.16 earnings per share for the current year.
This report was first posted by sleekmoney and is the property of of sleekmoney. If you are reading this report on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The legal version of this report can be viewed at http://sleekmoney.com/rgt-capital-management-ltd-invests-212000-in-thermo-fisher-scientific-inc-tmo/1659972.html.
Several equities research analysts have issued reports on the company. Zacks Investment Research upgraded Thermo Fisher Scientific from a “sell” rating to a “hold” rating in a report on Monday. Leerink Swann began coverage on Thermo Fisher Scientific in a report on Thursday, November 10th. They issued an “outperform” rating and a $175.00 price target for the company. Deutsche Bank AG reiterated a “buy” rating and issued a $163.00 price target on shares of Thermo Fisher Scientific in a report on Wednesday, January 18th. Evercore ISI boosted their price target on Thermo Fisher Scientific from $160.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, January 31st. Finally, Goldman Sachs Group, Inc. (The) reiterated a “conviction-buy” rating and issued a $168.00 price target (down from $170.00) on shares of Thermo Fisher Scientific in a report on Monday, December 12th. Three analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus price target of $169.71.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/rgt-capital-management-ltd-invests-212000-in-thermo-fisher-scientific-inc-tmo/1659972.html
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.